Axio Lattice — Cross-Company Data Coordination

Product Description

Axio Lattice is the coordination layer for drug programs that run across multiple companies or sites. A pharma sponsor develops a process and a manufacturing partner scales it. The two sides never share systems or data standards.

Every company has its own software systems and its own data language. Not one are the same. The same measurement ends up in a different field, calculated a different way. So comparing a partner's information against your own means reconciling it by hand, every time.

Axio connects and translates between teams, so both sides can compare the same information without either one moving data or changing systems. The software runs inside each company's own systems, so the records never leave.

The result: faster tech transfers, faster investigations, and data that is AI-ready.

Axio BioPharma

  • Country/Region:
    United States
  • Founded:
    2024
  • On CPHI since:
    2024
  • Employees:
    1 - 24
Company types
IT/Software solution provider
Primary activities
Technology
Specifications
  • Details
    Application areas: technology transfer between a sponsor and a manufacturing partner. Deviation and batch investigations that span two companies' systems. Process comparability across sites and partners.

    Source systems:
    LIMS, ELN, MES, historians, instrument data.

    Deployment:
    inside each participant's own environment — on premises, in their own cloud, or hosted.

    Access: read-only. No changes to source systems, records, or batch history. The source system stays the system of record.

    Stage: first engagement is non-GMP and retrospective. Architected to withstand the regulatory scrutiny this industry applies; formal validation is a separate, later step.

  • Selling Points
    Convenience; Product Features; Product Performance; Quality Service; Small Orders Accepted; Neither company adopts the other's vocabulary. Local terms are carried alongside the shared ones rather than replaced, which is what makes participation possible for a manufacturing partner serving competing sponsors. Ownership never changes hands. Every result traces back to the record it came from: the source file, the connector run, and the version of the translation that produced it. Founded by a commercial biomanufacturing operator and an early CrowdStrike engineer.
  • Supplied from
    Ireland; United States

Axio BioPharma

  • Country/Region:
    United States
  • Founded:
    2024
  • On CPHI since:
    2024
  • Employees:
    1 - 24
Company types
IT/Software solution provider
Primary activities
Technology

More Products from Axio BioPharma (1)

  • Axio Forge — Research-Grade Antibody Production

    Product Axio Forge — Research-Grade Antibody Production

    Axio Forge produces research-grade monoclonal antibodies for discovery-stage programs. We run high-throughput campaigns from our own laboratory in Madison, Wisconsin, and deliver purified, characterized material in 3-5 weeks.


    This is the work before a program commits to a candidate: screen...